Alimentary Health Ltd Recognised for Excellence in Research Innovation based on the Targeted PrecisionBiotic® 35624™ Culture for Digestive Health
Alimentary Health has been selected as a finalist in the 2015 The US-Ireland Research Innovation Awards. These prestigious awards recognise excellence and showcase the very best in research innovation in Ireland as a result of US foreign direct investment.
Developed by the American Chamber of Commerce Ireland and the Royal Irish Academy, these awards acclaim exemplary ideas, originating in Ireland, which have made a social and economic impact through research innovation in meeting market needs.
Alimentary Health was shortlisted for its global innovation specifically, the 35624™ culture. The 35624™ culture is a unique strain of the Bifidobacterium infantis family. It is a specialised patented precision bacterial culture (PrecisionBiotic®) developed by Irish and US scientists in Ireland. This unique technology, available over-the-counter is sold by Alimentary Health in Ireland as Alflorex® and by Procter & Gamble in North America as Align®. 'Align' is the first successful product launch for P&G in the probiotic category and has already received the ‘Gold Edison Award for Best New Product in 2010’ in the US. Furthermore, despite being on the market only 1 year in Ireland, ‘Alflorex®’ was awarded ‘Best Irish Pharmacy Product 2015’ by Irish Pharmacies.
In response to news of the nomination, Dr Barry Kiely said;
“It is a tremendous honour for the Alimentary Health team to have been selected as a finalist for such an esteemed scientific innovation award. There was strong competition this year from a number of high-profile organisations, so being selected as an SME category finalist is indeed a significant achievement. Alimentary Health’s roots are in research. Since the start we have continued to invest heavily in research. In 2003, when the company was young, we saw the value of this and co-invested with Government to establish the APC Microbiome Institute in Cork as foundation industry partner, and we continue this involvement today. This commitment to research and innovation has provided Alimentary Health with a rich pipeline of new products which we plan to bring to a global market over the next three years”.